ConductScience.org, home

Comparison · NCT02004613-8b50ad71

Dexmedetomidine vs Placebo: Number of Patients With Atrial Arrhythmia

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Dexmedetomidine vs Placebo: Number of Patients With Atrial Arrhythmia. Trial comparisons, record NCT02004613-8b50ad71. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02004613-8b50ad71

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.3050.2620.352wilson
Risk in group 20.3390.2940.387wilson
Risk difference, group 1 minus group 2-0.0345-0.09910.0306newcombe hybrid score
Risk ratio, group 1 over group 20.8980.7341.1log
Odds ratio, group 1 over group 20.8540.6341.15log
Number needed to treat, for one fewer participant with the outcome on Dexmedetomidine than on Placebo29from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Dexmedetomidine
Dexmedetomidine infusion, without a bolus dose, (or a comparable volume of placebo) will be initiated before the surgical incision at a rate of 0.1 mcg/kg/hr at the end of bypass, the dose will be increased to 0.2 mcg/kg/hr. Postoperatively patients will continue to receive the study medication at a rate of 0.4mcg/kg/hr. The study medication infusion will be continued for a total of 24 hours from the initial administration time intra-operatively.~Dexmedetomidine: Dexmedetomidine
121397OG000
Group 2Placebonormal saline administration matching dexmedetomidine rate of infusion.~Placebo: Normal saline administration matching dexmedetomidine rate of infusion134395OG001

Outcome

Type
PRIMARY
Title
Number of Patients With Atrial Arrhythmia
Description
The occurrence of postoperative atrial arrhythmias
Time frame
From the end of surgery to postoperative day 5
Population
2 patients had no Atrial Arrhythmia data.

Source ClinicalTrials.gov

Trial

Title
Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
NCT number
NCT02004613
Phases
PHASE4
Conditions
Heart Disease
Interventions
Dexmedetomidine, Placebo
Lead sponsor
The Cleveland Clinic
Results first posted
2021-04-06

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02004613-8b50ad71